BridgeBio’s Neil Kumar on an underdog drug launch and wooing deal-hungry investors
Neil Kumar has for years contended his unorthodox drug company is overlooked by biotechnology investors. He may not have that problem for much longer. The company he leads, BridgeBio Pharma, is in the early stages of launching a treatment for a heart …